Coulter begins a Phase II trial

CLTR and partner SmithKline Beecham (SBH) began an open label U.S. Phase II trial of Bexxar radioimmunotherapy in combination with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chem...